Winton Group’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-18,598
| Closed | -$705K | – | 791 |
|
2024
Q3 | $705K | Sell |
18,598
-1,065
| -5% | -$40.4K | 0.05% | 384 |
|
2024
Q2 | $890K | Buy |
+19,663
| New | +$890K | 0.06% | 338 |
|
2023
Q2 | – | Sell |
-26,950
| Closed | -$1.7M | – | 1122 |
|
2023
Q1 | $1.7M | Buy |
26,950
+12,549
| +87% | +$789K | 0.1% | 254 |
|
2022
Q4 | $766K | Sell |
14,401
-5,710
| -28% | -$304K | 0.05% | 497 |
|
2022
Q3 | $1.13M | Sell |
20,111
-23,508
| -54% | -$1.32M | 0.07% | 372 |
|
2022
Q2 | $3.16M | Buy |
43,619
+6,607
| +18% | +$478K | 0.17% | 152 |
|
2022
Q1 | $2.94M | Buy |
37,012
+7,161
| +24% | +$569K | 0.15% | 142 |
|
2021
Q4 | $3.02M | Buy |
29,851
+6,836
| +30% | +$692K | 0.18% | 106 |
|
2021
Q3 | $2.12M | Sell |
23,015
-2,343
| -9% | -$216K | 0.12% | 168 |
|
2021
Q2 | $2.6M | Buy |
25,358
+2,088
| +9% | +$214K | 0.14% | 102 |
|
2021
Q1 | $2.27M | Buy |
23,270
+788
| +4% | +$76.9K | 0.13% | 109 |
|
2020
Q4 | $1.73M | Sell |
22,482
-32,219
| -59% | -$2.48M | 0.13% | 158 |
|
2020
Q3 | $4.03M | Buy |
54,701
+1,311
| +2% | +$96.6K | 0.13% | 205 |
|
2020
Q2 | $3.92M | Buy |
53,390
+4,473
| +9% | +$328K | 0.1% | 322 |
|
2020
Q1 | $2.83M | Sell |
48,917
-6,305
| -11% | -$364K | 0.07% | 456 |
|
2019
Q4 | $4.34M | Buy |
+55,222
| New | +$4.34M | 0.06% | 524 |
|
2019
Q3 | – | Sell |
-10,505
| Closed | -$834K | – | 1696 |
|
2019
Q2 | $834K | Buy |
10,505
+3,077
| +41% | +$244K | 0.02% | 473 |
|
2019
Q1 | $623K | Sell |
7,428
-1,483
| -17% | -$124K | 0.01% | 491 |
|
2018
Q4 | $1.05M | Sell |
8,911
-1,636
| -16% | -$193K | 0.02% | 340 |
|
2018
Q3 | $1.27M | Buy |
10,547
+2,122
| +25% | +$256K | 0.03% | 361 |
|
2018
Q2 | $971K | Buy |
8,425
+733
| +10% | +$84.5K | 0.02% | 440 |
|
2018
Q1 | $661K | Buy |
+7,692
| New | +$661K | 0.02% | 661 |
|